Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

ClinicalTrials.gov ID: NCT00578175

Public ClinicalTrials.gov record NCT00578175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity of GlaxoSmithKline Biologicals' MMRV Vaccine (208136) vs. ProQuad®, When Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children 12-14 Months of Age.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this observer blinded study is to provide information on vaccine immunogenicity and reactogenicity in comparison with the US standard of care (ProQuad®) when administered with Hepatitis A vaccine and Pneumococcal vaccine.

Study identification

NCT ID
NCT00578175
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
1,851 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
12 Months to 14 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2007 (Type not available)
Primary completion
Feb 24, 2009 (Actual)
Completion
Mar 17, 2009 (Actual)
Last update posted
Oct 9, 2018

2007 – 2009

United States locations

U.S. sites
141
U.S. states
36
U.S. cities
128
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205 —
GSK Investigational Site Birmingham Alabama 35244 —
GSK Investigational Site Tuscaloosa Alabama 35401 —
GSK Investigational Site Phoenix Arizona 85003 —
GSK Investigational Site Benton Arkansas 72015 —
GSK Investigational Site Jonesboro Arkansas 72401 —
GSK Investigational Site Little Rock Arkansas 72205 —
GSK Investigational Site Anaheim California 92804 —
GSK Investigational Site Anaheim California 92805 —
GSK Investigational Site Buena Park California 90620 —
GSK Investigational Site Downey California 90241 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Fremont California 94538 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Hayward California 94545 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site Lakewood California 90711 —
GSK Investigational Site Oakland California 94611 —
GSK Investigational Site Paramount California 90723 —
GSK Investigational Site Pleasanton California 94588 —
GSK Investigational Site San Francisco California 94115 —
GSK Investigational Site San Jose California 95119 —
GSK Investigational Site Torrance California 90502 —
GSK Investigational Site Vacaville California 95688 —
GSK Investigational Site West Covina California 91790 —
GSK Investigational Site Centennial Colorado 80112 —
GSK Investigational Site Thornton Colorado 80233 —
GSK Investigational Site Westminster Colorado 80234 —
GSK Investigational Site Boynton Beach Florida 33437 —
GSK Investigational Site Opa-locka Florida 33054 —
GSK Investigational Site Plantation Florida 33324 —
GSK Investigational Site West Palm Beach Florida 33407 —
GSK Investigational Site Carrollton Georgia 30117 —
GSK Investigational Site Dalton Georgia 30721 —
GSK Investigational Site Marietta Georgia 30062 —
GSK Investigational Site Tifton Georgia 31794 —
GSK Investigational Site Tucker Georgia 30084 —
GSK Investigational Site Woodstock Georgia 30189 —
GSK Investigational Site Honolulu Hawaii 96814 —
GSK Investigational Site Honolulu Hawaii 96819 —
GSK Investigational Site Nampa Idaho 208 463 3126 —
GSK Investigational Site DeKalb Illinois 60115 —
GSK Investigational Site Fishers Indiana 46038 —
GSK Investigational Site Indianapolis Indiana 46229 —
GSK Investigational Site Lafayette Indiana 47904 —
GSK Investigational Site New Albany Indiana 47150 —
GSK Investigational Site Dubuque Iowa 52001 —
GSK Investigational Site Dubuque Iowa 52002 —
GSK Investigational Site Waukee Iowa 50263 —
GSK Investigational Site West Des Moines Iowa 50266 —
GSK Investigational Site Arkansas City Kansas 67005 —
GSK Investigational Site Overland Park Kansas 66215 —
GSK Investigational Site Topeka Kansas 66608 —
GSK Investigational Site Wichita Kansas 67208 —
GSK Investigational Site Bardstown Kentucky 40004 —
GSK Investigational Site Lexington Kentucky 40503 —
GSK Investigational Site Louisville Kentucky 40202 —
GSK Investigational Site Louisville Kentucky 40272 —
GSK Investigational Site Louisville Kentucky 40291 —
GSK Investigational Site Owensboro Kentucky 43202 —
GSK Investigational Site Springfield Kentucky 40069 —
GSK Investigational Site Baltimore Maryland 21201 —
GSK Investigational Site Frederick Maryland 21702 —
GSK Investigational Site Fall River Massachusetts 02724 —
GSK Investigational Site Woburn Massachusetts 01801 —
GSK Investigational Site Kalamazoo Michigan 49008 —
GSK Investigational Site Niles Michigan 49120 —
GSK Investigational Site Portage Michigan 49024 —
GSK Investigational Site Richland Michigan 49083 —
GSK Investigational Site Stevensville Michigan 49127 —
GSK Investigational Site Brainerd Minnesota 56401 —
GSK Investigational Site Saint Paul Minnesota 55108 —
GSK Investigational Site Bridgeton Missouri 63044 —
GSK Investigational Site Columbia Missouri 65203 —
GSK Investigational Site Kansas City Missouri 64108 —
GSK Investigational Site Bellevue Nebraska 68123 —
GSK Investigational Site Omaha Nebraska 68131 —
GSK Investigational Site Omaha Nebraska 68132 —
GSK Investigational Site Henderson Nevada 89015 —
GSK Investigational Site Las Vegas Nevada 89101 —
GSK Investigational Site Whitehouse Station New Jersey 08889 —
GSK Investigational Site Johnson City New York 13790 —
GSK Investigational Site Lake Success New York 11040 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site Rochester New York 14618 —
GSK Investigational Site Stony Brook New York 11794 —
GSK Investigational Site Syracuse New York 13205 —
GSK Investigational Site Utica New York 13502 —
GSK Investigational Site Boone North Carolina 28607 —
GSK Investigational Site Cary North Carolina 27518 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Sylva North Carolina 28779 —
GSK Investigational Site Fargo North Dakota 58103 —
GSK Investigational Site Minot North Dakota 58701 —
GSK Investigational Site Cincinnati Ohio 45245 —
GSK Investigational Site Dayton Ohio 45406 —
GSK Investigational Site Fairfield Ohio 45014 —
GSK Investigational Site Huber Heights Ohio 45424 —
GSK Investigational Site Tulsa Oklahoma 74107 —
GSK Investigational Site Eugene Oregon 97402 —
GSK Investigational Site Gresham Oregon 97030 —
GSK Investigational Site Altoona Pennsylvania 16602 —
GSK Investigational Site East Norriton Pennsylvania 19401 —
GSK Investigational Site Kittanning Pennsylvania 16201 —
GSK Investigational Site Latrobe Pennsylvania 15650 —
GSK Investigational Site Pittsburgh Pennsylvania 15213 —
GSK Investigational Site Pittsburgh Pennsylvania 15217 —
GSK Investigational Site Pittsburgh Pennsylvania 15236 —
GSK Investigational Site Sellersville Pennsylvania 18960 —
GSK Investigational Site Uniontown Pennsylvania 15401 —
GSK Investigational Site Wexford Pennsylvania 15090 —
GSK Investigational Site Charleston South Carolina 29406 —
GSK Investigational Site Brentwood Tennessee 37027 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Nashville Tennessee 37203 —
GSK Investigational Site Amarillo Texas 79124 —
GSK Investigational Site Bryan Texas 77802 —
GSK Investigational Site Corpus Christi Texas 78411 —
GSK Investigational Site Lubbock Texas 79430 —
GSK Investigational Site San Antonio Texas 78205 —
GSK Investigational Site San Antonio Texas 78212 —
GSK Investigational Site San Antonio Texas 78215 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Sugar Land Texas 77479 —
GSK Investigational Site Layton Utah 84041 —
GSK Investigational Site Ogden Utah 84405 —
GSK Investigational Site Provo Utah 84604 —
GSK Investigational Site South Jordan Utah 84095 —
GSK Investigational Site St. George Utah 84790 —
GSK Investigational Site West Jordan Utah 84088 —
GSK Investigational Site Charlottesville Virginia 22902 —
GSK Investigational Site Charlottesville Virginia 22903 —
GSK Investigational Site Chesapeake Virginia 23321 —
GSK Investigational Site Midlothian Virginia 23113 —
GSK Investigational Site Vienna Virginia 22180 —
GSK Investigational Site Virginia Beach Virginia 23454 —
GSK Investigational Site Huntington West Virginia 25701 —
GSK Investigational Site La Crosse Wisconsin 54601 —
GSK Investigational Site Madison Wisconsin 53792 —
GSK Investigational Site Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00578175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00578175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →